Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dylan C Dean

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Therapeutic Advances in Medical Oncology|May 20, 2020
Myc is a prognostic biomarker and potential therapeutic target in osteosarcomaWenlong Feng, Dylan C Dean, Francis J Hornicek, et al.
Molecular Oncology|June 11, 2021
T-LAK cell-originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcomaPichaya Thanindratarn, Ran Wei, Dylan C Dean, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 3, 2022
Inhibition of CDK7-dependent transcriptional addiction is a potential therapeutic target in synovial sarcomaXiaoyang Li, Dylan C Dean, Jin Yuan, et al.
Clinical Orthopaedics and Related Research|September 28, 2023
Discoidin Domain Receptor Tyrosine Kinase 1 (DDR1) Is a Novel Therapeutic Target in Liposarcoma: A Tissue Microarray StudyDylan C Dean, Wenlong Feng, Robert L Walker, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Therapeutic Advances in Medical Oncology|May 20, 2020
Myc is a prognostic biomarker and potential therapeutic target in osteosarcomaWenlong Feng, Dylan C Dean, Francis J Hornicek, et al.
Molecular Oncology|June 11, 2021
T-LAK cell-originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcomaPichaya Thanindratarn, Ran Wei, Dylan C Dean, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 3, 2022
Inhibition of CDK7-dependent transcriptional addiction is a potential therapeutic target in synovial sarcomaXiaoyang Li, Dylan C Dean, Jin Yuan, et al.
Clinical Orthopaedics and Related Research|September 28, 2023
Discoidin Domain Receptor Tyrosine Kinase 1 (DDR1) Is a Novel Therapeutic Target in Liposarcoma: A Tissue Microarray StudyDylan C Dean, Wenlong Feng, Robert L Walker, et al.
Pageof 3